Bml, Inc.

Bml, Inc., a Tokyo-based laboratory services provider, operates as a prime contractor delivering clinical laboratory testing, diagnostic analysis, and reference laboratory services exclusively to Department of Defense medical commands, with 100% of its federal work conducted through non-set-aside, full-and-open competition. The company competes in the open market without SBA designations and maintains federal contracting registration dating to 2004.

The vendor's customer concentration is extreme and non-diversified. The Department of the Navy Bureau of Medicine and Surgery accounts for 189 awards (74% of the 256-award footprint) worth $296.8 million combined potential value — a dominance that dwarfs secondary customers. The Defense Health Agency has 29 awards worth $4.5 million, and the Department of the Air Force Pacific Air Forces carries 28 awards worth $33.6 million. The top three agencies account for 99% of awards by count. Obligated dollars total $11.7 million against $335.4 million in combined potential value, reflecting the contract portfolio's forward-looking nature rather than invoiced revenue concentration.

Bml, Inc.'s capability portfolio centers on clinical laboratory testing and diagnostic services for U.S. military personnel stationed in Japan and the Pacific region. Work spans COVID-19 PCR testing, polymerase chain reaction screenings, general clinical laboratory analysis, reference laboratory services, and frozen-sample analysis. Representative prime work includes a $1,792,738.92 single-award Indefinite Delivery Contract with the Defense Health Agency running through September 30, 2028, under which Bml issues task orders ranging from $1,522.28 to $79,254.91; a $76,774.03 delivery order from the Defense Health Agency for laboratory testing services (January 2026); and a $135,721.75 delivery order from Pacific Air Forces for COVID-19 laboratory testing at Yokota Air Base (July 2022). The vendor also holds a $250,000 single-award BPA with the Defense Health Agency for frozen-sample analysis at Camp Zama through August 31, 2030, and a $60,000 single-award BPA with Pacific Air Forces for reference laboratory services at Misawa Air Base through December 31, 2026.

Place of performance is Japan across all awards. Bml serves multiple military installations including Naval Hospital Yokosuka, Yokota Air Base, Misawa Air Base, Camp Zama, and Naval Hospital Okinawa. The company performs services directly without identified major subcontractors and maintains an operational footprint across the region.

Activity has declined sharply: 20 awards in 2022, 15 in 2023, 12 in 2024, 6 in 2025, and 2 in 2026 year-to-date. This trajectory reflects either a shift toward larger task orders under standing IDVs rather than new delivery orders, or a genuine contraction in volume. Only $146 thousand in combined potential value faces completion within the next twenty-four months, indicating minimal recompete exposure and limited near-term opportunity for displacement. The vendor's footprint rests on sustained partnership with Navy Bureau of Medicine and Surgery through recurring monthly or quarterly delivery orders, each individually small but collectively representing the bulk of the contract portfolio.